menu
    • menu

    Company profile for SynOx Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SynOx is a clinical stage biopharmaceutical company. It is a spin out from Celleron Therapeutics Ltd, an oncology company focused on the clinical development of new and innovative therapies to treat cancer. SynOx is developing emactuzumab, a best-in-class CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue. SynOx is led by a team of experts that combines biote...
    SynOx is a clinical stage biopharmaceutical company. It is a spin out from Celleron Therapeutics Ltd, an oncology company focused on the clinical development of new and innovative therapies to treat cancer. SynOx is developing emactuzumab, a best-in-class CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue. SynOx is led by a team of experts that combines biotech and pharma experience with a successful track record of developing and bringing products to market. It is backed by a strong investor syndicate – HealthCap, Medicxi, Forbion and Gimv.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SynOx TherapeuticsIreland Flag
    Country
    Country
    Ireland
    Address
    Address
    Wilton Terrace, 7/8, Dublin City, County Dublin D02 KC57, IE
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://synoxtherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/synox-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Synox Therapeutics Bolsters Board With Commercialization
    Synox Therapeutics Bolsters Board With Commercialization

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170036/0/en/SynOx-Therapeutics-Strengthens-Board-of-Directors-with-Leading-Experts-in-Commercialisation-and-Corporate-Development-Amid-Continued-Corporate-Progress.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Synox Completes Enrollment Early in Ph 3 Tangent Trial
    Synox Completes Enrollment Early in Ph 3 Tangent Trial

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127204/0/en/SynOx-Therapeutics-Completes-Enrollment-in-Registrational-Phase-3-TANGENT-Clinical-Trial-Significantly-Ahead-of-Timeline.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    SynOx Therapeutics Gets Fast Track for Emactuzumab for TGCT Tumours
    SynOx Therapeutics Gets Fast Track for Emactuzumab for TGCT Tumours

    14 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/14/3060798/0/en/SynOx-Therapeutics-Receives-Fast-Track-Designation-from-U-S-Food-and-Drug-Administration-for-Emactuzumab-for-Tenosynovial-Giant-Cell-Tumours-TGCT.html

    GLOBENEWSWIRE
    14 Apr 2025
    Share Share
    SynOx Therapeutics Announces Board Chair Transition for Strategy
    SynOx Therapeutics Announces Board Chair Transition for Strategy

    01 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/01/3053137/0/en/SynOx-Therapeutics-Announces-Board-Chair-Transition-to-Align-with-Advancing-Regulatory-and-Commercialization-Strategy.html

    GLOBENEWSWIRE
    01 Apr 2025
    Share Share
    SynOx Appoints U.S.-Based CMO & CCO to Strengthen Executive Team
    SynOx Appoints U.S.-Based CMO & CCO to Strengthen Executive Team

    07 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/07/2976482/0/en/SynOx-Therapeutics-Further-Strengthens-Executive-Team-with-Appointments-of-U-S-Based-Chief-Medical-Officer-and-Chief-Commercial-Officer.html

    GLOBENEWSWIRE
    07 Nov 2024
    Share Share
    SynOx Therapeutics Raises $92M in Series B, Doses First Patients
    SynOx Therapeutics Raises $92M in Series B, Doses First Patients

    30 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/30/2971571/0/en/SynOx-Therapeutics-Adds-New-Investor-and-Capital-to-Series-B-Financing-Raising-Total-to-92-Million-and-Doses-First-Patients-in-Phase-3-Trial.html

    GLOBENEWSWIRE
    30 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search